BioNTech SE BNTX
NASDAQ BNTX
$96.85 -1.45 (-1.48%)
At close: Oct 1, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Liabilities and Shareholders Equity (2018 - 2026)

Updated

BioNTech SE's Liabilities and Shareholders Equity came in at $23.65 billion for Q2 2026, down 3.5% from $24.49 billion a year earlier and down 4.2% from the prior quarter.

Analysis

BioNTech SE (BNTX) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, BioNTech SE's Liabilities and Shareholders Equity was $25.6 billion, up 6.3% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 57.4% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $24.08 billion in FY2024 (-2.7%), $24.75 billion in FY2023 (+4.2%), $23.75 billion in FY2022 (+31.1%) and $18.11 billion in FY2021 (+584.1%).
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q1 2025.
  • Year-over-year, Liabilities and Shareholders Equity increased in five of the last eight quarters, with growth averaging 1.1%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q3 2021 (growth of 891.5%), and the weakest in Q1 2025 (a decline of 7.8%).
  • Business Quant data shows BNTX's Liabilities and Shareholders Equity at $24.67 billion (Q1 2026), $25.6 billion (Q4 2025) and $24.95 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 BioNTech SE 24.86 Bn -34.51 Bn 10.00 Mn 23.65 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.65 Bn
Mar 31, 2026 24.67 Bn
Dec 31, 2025 25.60 Bn
Sep 30, 2025 24.95 Bn
Jun 30, 2025 24.49 Bn
Mar 31, 2025 22.28 Bn
Dec 31, 2024 24.08 Bn
Sep 30, 2024 24.60 Bn
Jun 30, 2024 23.95 Bn
Mar 31, 2024 24.18 Bn
Dec 31, 2023 24.75 Bn
Sep 30, 2023 24.17 Bn
Jun 30, 2023 24.20 Bn
Mar 31, 2023 23.70 Bn
Dec 31, 2022 23.75 Bn
Sep 30, 2022 22.85 Bn
Jun 30, 2022 22.57 Bn
Mar 31, 2022 22.78 Bn
Dec 31, 2021 18.11 Bn
Sep 30, 2021 16.78 Bn
API Access

BioNTech SE Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BNTX&period=max&api_key=YOUR_API_KEY